Use CasesESEQuant Go: Digitising a next generation handheld reader

ESEQuant Go

ESEQuant Go: Digitising a next generation handheld reader


I find you very open, honest and friendly. I was impressed by how quickly your team created the prototype app from the sketches of the workflow we sent. It looked elegant and it all happened with very few phone calls.

I would recommend Bond because of the uncomplicated and clear structure you have. You know what you’re doing, you’re focussed on a certain field and have expertise in it.

Christian Fischer-Rasokat, Global Product Manager, DIALUNOX


DIALUNOX is a subsidiary of QIAGEN corporation and is a world-leading provider of point-of-use testing devices, specifically lateral flow assays and reader technologies. The company has been in the reader business for more than 15 years and has become a centre of excellence for optical detection, with a global client base.

Dialunox’s rapid test readers range from bench top laboratory systems to more portable, out-of-lab solutions. These have countless applications, from food safety and veterinary diagnostics to their use in human health and infectious disease diagnostics.


Even though DIALUNOX has a solid product portfolio, something was missing. With self-testing and with connectivity becoming a priority, the company recognised a demand among customers for a smaller, low cost reader solution that offered reliable cloud connectivity.

Such a solution would fit perfectly in the lifestyle consumer diagnostics area, but also in more complex environments like in-vitro diagnostics. The market needed a smart, handy reader that could fit in a pocket and be used by anyone, anywhere in the field.

ESEQuant Go emerged as a proposal for development that followed the evolution of the company’s reader technologies. It was an exciting prospect that would enable them to offer the whole range of reader solutions.

Aims & Challenges

DIALUNOX offers its own connectivity health software but it is a separate piece of kit that was designed to be used in a hospital / lab setting and only by trained experts.

To capture the home testing market, the company needed to come up with an idea for a wireless device that was extremely intuitive and user-friendly.

With home use and portability in the lifestyle area, where anyone can be using the kit, it’s much better to use smartphones that benefit from high connectivity and 4G, 5G networks.

For the ESEQuant Go project, connectivity meant that the device should be able to collect and transfer data into backend cloud systems at the point of use. It was important to automate and simplify the process as much as possible for the end user.

They turned to Transform® from Bond Digital Health and their health data analytics platform.


Bond took a collaborative approach towards building the first version of an ESEQuant Go demonstrator. DIALUNOX developed the initial product design concept and supplied some sketches of the graphic user interface. We then took these sketches and built a beautiful mobile app with two main functions:

  • To guide the user through the testing process by displaying a step-by-step on-screen tutorial, also referred to as Instructions for Use (IFU).
  • To connect the reader to the phone and the cloud so that test results can be instantly gathered, displayed and stored for future use. Results history could be accessed at any time in the app.

Results & Future

Though only a prototype, this version of ESEQuant Go enabled DIALUNOX to complete its portfolio and fulfil the needs of an important and growing segment of the lateral flow market. It would also provide feedback for further development and enable new conversations with potential clients.

When asked what he saw as the next steps for this project, DIALUNOX’s Global Product Manager Christian Fischer-Rasokat said:
“We need to talk about starting the first proper application development for a customer. We want to use your TRANSFORM™ platform because of the missing link we have with connectivity and cloud services.

Anyone using a phone with apps is used to have connectivity and to see trends of health data, live status and so on. In the consumer diagnostics field, there is no question that this technology is needed and it is state of the art to have it. Customers are then much more open to using it and they like it.”


Wireless readers, facilitated by Bond’s TRANSFORM™ platform, offer exciting benefits that are becoming difficult to ignore. Christian added:

“The ability to monitor users at different geographic sites is a very powerful feature because it enables more personalised advice and warnings to be sent. On the app, the user only sees their own data, but the dashboard collates multi-device data and allows for trends to be spotted in an interactive, visual way. This is something we want to use.

The mapping of disease outbreaks in particular is of interest to big pharmaceutical companies who are involved in the diagnostics field. If you’re looking at projects with the WHO or FIND in the Sub-Saharan area, then you have to use mobile networks because there’s no wired


Together, we’re creating a digitally-connected and portable lateral flow reader. It’s groundbreaking and a great exemplar of the new generation of smart readers which come with the computing power of the cloud. We built a user interface app to facilitate data transfer and connect results from the reader to algorithms in the cloud.

Christian Fischer-Rasokat, Global Product Manager, DIALUNOX

Want to work with us?